Find XO: Agentic AI Enters the Bio Lab (venturesquare.net)

- This article frames the fusion of agentic AI and bio as an opportunity, but the two trends move at quite different speeds. - Agentic AI, which eliminates repetitive tasks, is already felt at a tool level, but bio requires proving commercial viability and clinical applications before money flows. - Increasing agreements and support systems doesn't speed up that proof. - Even under the same term 'fusion,' it is right to set separate investment timelines.